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Abstract
Antimicrobial resistance has been recognised as one of the most difficult challenges facing human and animal
health in recent decades. The surveillance of antimicrobial use in animal health plays a major role in dealing with
the growing issue of resistance. This paper reviews current data available on antimicrobial use in farmed animals in
the Republic of Ireland, including each of the major livestock production sectors; pigs, poultry, dairy, beef and
sheep. A systematic literature search was conducted to identify relevant published literature, and ongoing research
was identified through the network of authors and searches of each of the research databases of the main
agriculture funding bodies in Ireland. The varying quantities and quality of data available across each livestock
sector underlines the need for harmonisation of data collection methods. This review highlights the progress that
has been made regarding data collection in the intensive production sectors such as pigs and poultry, however, it
is clear there are significant knowledge gaps in less intensive industries such as dairy, beef and sheep. To comply
with European regulations an antimicrobial data collection system is due to be developed for all food-producing
animals in the future, however in the short-term surveillance studies have allowed us to build a picture of current
use within the Republic of Ireland. Further studies will allow us to fill current knowledge gaps and build a more
comprehensive overview of antimicrobial use in farm animals in Ireland.
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Introduction
Antimicrobials (AM) are a vital tool in both human and
animal health. However, overuse of AM can contribute
to the development of antimicrobial resistance (AMR)
[1] which has been recognised as a global issue for hu-
man and animal health in recent decades. Antimicrobials
are used in significant quantities in agriculture and this
use can lead to the development of AMR in bacteria in
animals [2], which may be transmitted to humans
through direct contact with animals, the food chain or
the environment [3]. Many of the same AM that are
used in humans are also used to treat infections in
animals, including AM listed by the World Health Or-
ganisation (WHO) as ‘critically important’ (CIAs) for
humans [4]. The overuse of CIAs may result in the loss
of their efficacy due to development of AMR, therefore
once-treatable human infections may become potentially
fatal.
Since 2005, the WHO has produced a regularly up-
dated list of all AM currently used for human medicine
(most are also used in veterinary medicine), grouped
into 3 categories based on their importance to human
medicine [4]. Within the European Union (EU), the
European Medicines Agency (EMA) have published a list
categorising AM for use in animals prepared by the
Antimicrobial Advice Ad Hoc Expert Group (AMEG).
The European classification now comprises four categor-
ies, from A to D: Avoid, Restrict, Caution and Prudence,
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respectively. The categorisation of AM classes for veter-
inary use in the EU, with examples of active substances
per class, is available on the EMA’s website [5]. The cat-
egorisation is intended as a tool to support decision-
making by veterinarians on which AM is appropriate to
use to reduce the threat of AMR development.
In 2015, the WHO published the Global Action Plan
on AMR [6] including five strategic objectives to combat
the threat of AMR to both human and animal health. A
key objective of the WHO Global Action Plan on AMR
focuses on strengthening knowledge of AMR and anti-
microbial use (AMU) through surveillance [6]. Reliable
data on the quantities of AM used are needed to bench-
mark usage, observe trends over time and to monitor
the response to any interventions to reduce use [7].
Within the EU, the EMA promotes the prudent use of
AM in humans and animals, and the collection of AMU
data. EU member states are encouraged to record and
report usage data in both human and animal health so
that the impact of policy change may be monitored.
Additionally, new EU Veterinary Medicines Regulations
(EU) 2019/6 [8] will make it a requirement for AM pre-
scription data on all food-producing animals to be col-
lected in a national AM consumption database from
January 2027.
Several EU member states, such as Belgium [9],
Denmark [10], France [11], Sweden [12], the Netherlands
[13] and the United Kingdom (UK) [14] publish annual re-
ports on the consumption of veterinary AM at a national
level. The introduction of surveillance programmes, based
on routine, farm-level collection of usage data, has allowed
many of these countries to make significant progress in re-
ducing their AMU. In the Republic of Ireland, national
usage data is not yet collected at farm level. However, the
Department of Agriculture, Food & the Marine (DAFM)
introduced an AM database collection system for com-
mercial pig herds in November 2019, with plans to de-
velop similar systems for other livestock sectors to comply
with new EU legislation [8].
In 2017, Ireland published the National Action Plan
on Antimicrobial Resistance 2017–20 (iNAP) [15]. This
report outlines the steps needed to reduce the threat of
AMR from the agricultural sector, including the collec-
tion of AMU data. As yet, there is no real-time collec-
tion of AMU data in Ireland. However, there are several
examples of research conducted in Ireland to quantify
AMU across the various livestock sectors. An all-island
review of current AMU was not feasible as data from
Northern Ireland are generally aggregated with data
from Great Britain. Therefore, the purpose of this study
was to review current AMU in the Republic of Ireland
across and within the range of agricultural sectors, based
on data that are available, to review current method-
ology that is being used to quantify AMU, and to
identify gaps in sector-specific AMU that are not cur-
rently addressed in published or ongoing research.
Materials and methods
Systematic literature review of AMU
A systematic literature search was conducted using the
databases PubMed and CAB Direct to identify relevant
articles. The literature search was limited to articles pub-
lished during 2010–2019. An initial search was first car-
ried out for literature in all animal production sectors.
Next, separate, independent searches were performed
for each of the major production sectors; pigs, poultry,
dairy, beef and sheep, with the final search results
pooled. The search terms used were:
1. (((Antimicrobial) OR Antibiotic) AND Ireland)
AND Animal Production
2. (((Antimicrobial) OR Antibiotic) AND Ireland)
AND Pig OR Swine
3. (((Antimicrobial) OR Antibiotic) AND Ireland)
AND Poultry OR Broiler OR Chicken OR Layer
4. (((Antimicrobial) OR Antibiotic) AND Ireland)
AND Dairy OR Cattle OR Calf
5. (((Antimicrobial) OR Antibiotic) AND Ireland)
AND Beef
6. (((Antimicrobial) OR Antibiotic) AND Ireland)
AND Sheep
The titles of search results were screened by the first
author. The criteria for selecting an article based on the
title was the inclusion of the following phrases or ideas
related to them: antibiotic use or therapy, antimicrobial
use or therapy, or in-feed medication. Articles with rele-
vant titles were exported and their abstracts were
screened. Potentially eligible full-text manuscripts were
then reviewed, and irrelevant articles were excluded. In-
clusion criteria required that the articles dealt with one
of the following categories of information: quantifying
antimicrobial use, describing antimicrobial usage pat-
terns, or collection of antimicrobial usage data.
Ongoing AMU research
A search was conducted to identify ongoing research
projects in the area of AMU in animal production within
Ireland. Searches were conducted of each of the research
databases of the main agriculture funding bodies in
Ireland.
DAFM
The Department of Agriculture, Food & the Marine
(DAFM) funds projects under three competitive funding
research programmes for agriculture, food and forestry.
The summary details and final reports (if available) of
current and ongoing projects are published on their
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website along with the names of the principal investiga-
tors [16]. A search was carried out of the DAFM website
to identify relevant projects.
Safefood
safefood is the Irish Food Safety Promotion Board. safe-
food funds research on the island of Ireland in the areas
of food safety, food hygiene, nutrition and healthy eating,
and publishes information on funded projects on their
website [17]. A description of the project is given, and
any associated published reports, digital resources and
peer-reviewed publication are listed. A search was con-
ducted of the research portfolio on the safefood website,
and project titles were then screened for relevance.
Teagasc
Teagasc, Ireland’s national Agriculture and Food Devel-
opment Authority provides training and advisory ser-
vices to the agriculture and food industry as well as
undertaking research. Teagasc provides funding for re-
search in four main areas: ‘Animal and Grassland Re-
search and Innovation’; ‘Crops, Environment and Land
Use’; ‘Food’ and, ‘Rural Economy and Development’ [18].
A search was carried out of the Teagasc website to iden-
tify relevant projects funded through internal Teagasc
funds and the Teagasc Walsh Fellowship fund. In
addition, a search was conducted of the Teagasc TRe-
search publications. Teagasc TResearch is a technical
science publication that communicates the scientific
work being undertaken in Teagasc and collaborating re-
search institutions. The search was limited to articles
published in the last 10 years, 2010–2019. The same in-
clusion criteria as used in the systematic literature
search were applied here.
Antimicrobial sales
Since 2009, the Health Products Regulatory Authority
(HPRA; known as the Irish Medicines Board (IMB) prior
to 2014) has produced an annual report on sales of vet-
erinary AM in the Republic of Ireland. The report col-
lates data on AM sales for the previous year provided to
the HPRA by the marketing authorisation holders that
market veterinary AM. The data is submitted to the
EMA as part of the European Surveillance of Veterinary
Antimicrobial Consumption (ESVAC) project. A search




Systematic literature review of AMU
Figure 1 illustrates the search process for peer-reviewed
published literature. Three articles discussing AMU in
Irish pigs were identified from the database search.
These articles discuss patterns of AMU and the effects
on AMR, health and welfare [19–21]. Three articles were
available on AMU in the dairy sector [22–24]. One art-
icle was available for the beef sector discussing AMU in
calves [25]. No peer-reviewed data were available for
current AMU in the poultry or sheep production
sectors.
Ongoing AMU research
The search for ongoing AMU research identified work
that has been carried out in the pig and poultry sectors
under the Antimicrobial Use and Resistance in Animal
Production (AMURAP) project funded by DAFM [26].
This project aims to gain a deeper understanding of the
current AMU on commercial Irish pig farms and broiler
crops. AMURAP is on-going and has to date focused on;
the classes and quantities of AM used, and the patterns
of use. Farm-level data has been recorded for the broiler
sector as part of the AMURAP project, although this
data has not yet been published [27]. The search also
Fig. 1 Flow diagram of the database search process for identifying
relevant peer-reviewed publications
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revealed projects funded by Teagasc and DAFM such as
WELPIG and PATHSURVPIG which have explored the
relationship between AMU, respiratory disease and wel-
fare in pigs [19, 20]. Within the dairy industry, data on
intramammary AMU for the years 2016–2019 have been
analysed and are currently under review.
Antimicrobial sales
Ten reports on the consumption of veterinary AM were
available on the HPRA website. Reports were available
for the years 2009–2018. The reports provide a figure
for the total tonnage of veterinary AM sold that year
and breaks this figure down into AM classes and
pharmaceutical form. Reports from the last 5 years were
analysed [28–32].
National AMU
The total amount of veterinary AM sold in Ireland in
2018 was 99.4 t [28]. Figure 2 depicts the breakdown of
AM supplied to the market in pharmaceutical form sold
for 2018.
Over the last 5 years the sales of veterinary antimicro-
bials have remained between approximately 90–100 t
(Table 1). The distribution of sales in classes of AM sold
for the years 2014–2018 are illustrated in Fig. 3. The
classes of AM sold have not changed substantially over
the last 5 years. The sales of fluoroquinolones, classed as
Category B (‘Restrict’) by the EMA, have remained rela-
tively constant over this period, while the sales of the
Category C (‘Caution’) macrolides and Category B 3rd &
4th generation cephalosporins have increased (Table 1).
The sales data collected by the HPRA is submitted to
the EMA under the ESVAC project, and the EMA pub-
lishes an annual report on the sales of veterinary AM in
Europe, the most recent report published in 2019 is
based on data from 2017 submitted by 31 European
countries [33]. The amounts of veterinary AM sold are
reported in tonnes of active ingredient and in mg of ac-
tive substance per Population Correction Unit (PCU)
where PCU is an estimate of weight at treatment defined
for each species. PCU is a theoretical unit of measure-
ment developed by the EMA in 2009 [34]. The estimated
PCU for Ireland (in 1000 t) of the population of food-
producing animals for 2017, was 2114 [33]. That year,
Ireland’s annual sales of veterinary AM was 99.7 t of ac-
tive ingredient or 46.6 mg/PCU [33]. In terms of Cat-
egory B AM, fluoroquinolones and 3rd & 4th generation
cephalosporins had figures of 0.4 mg/PCU and 0.1 mg/
PCU, respectively, in Ireland for 2017.
AMU by farm sector
Pigs
The AMURAP project analysed a range of data to quan-
tify AMU in the pig sector over a 12-month period in
2016. The total consumption of AM by weight of active
ingredient was 14.5 t for the sample population; this
sample represented one-third of the national population
of pig herds, suggesting the AMU for the population of
approximately 140,000 to 150,000 sows would be ap-
proximately 43.5 t of active ingredient. The total AMU
for the sample farms combined was 161.9 mg/PCU [35].
The largest group of AM used (by weight of active in-
gredient) were tetracyclines (55.8%), followed by sulpho-
namides and trimethoprim (25.2%), macrolides (9.3%)
and penicillins (7.8%), the remainder was made up of
other AM classes [36]. The use of AM categorised as
Category B was low in the study farms, however, the
number of farms exposed was high, especially for
fluoroquinolones.
Fig. 2 Pharmaceutical form breakdown of veterinary antimicrobials sold in Ireland in 2018 [28]
Table 1 Sales (tonnes sold) of veterinary antimicrobials
including 3rd & 4th generation cephalosporins,
fluoroquinolones & macrolides for the years 2014–2018 [28–32]
Year 2014 2015 2016 2017 2018
All AM classes 89.4 96.9 103.4 99.7 99.4
3rd & 4th gen. Cephalosporins 0.24 0.22 0.25 0.30 0.33
Fluoroquinolones 0.69 0.79 0.94 0.85 0.84
Macrolides 6.26 5.58 6.58 7.17 7.07
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In terms of routes of administration, 97.5% of AM
were administered orally; 89.2% in medicated feed, 7.2%
in water, 1.1% in oral powder and 0.03% in oral doses.
The remaining 2.5% was administered through inject-
ables [36]. The large proportion of AMU attributed to
oral remedies indicates AM are most frequently applied
as group treatments. Analysis of AMU in medicated feed
showed that 75.5% of all AM used in pig production are
administered to pigs in the post weaning stages of pro-
duction (4–13 weeks old).
Patterns of AMU in medicated feed on pig farms in
Ireland are also described in a separate study carried out
by Gibbons and colleagues, although this study does not
provide quantities of AM used [21]. The findings are in
agreement with those of O’Neill and colleagues [36] in
that AM were frequently administered in the post wean-
ing stages.
Poultry
Due to the confidentiality agreement between the re-
searchers and the producers who provided the data it
was not possible to report the quantities of AM used by
the broiler crops in the AMURAP project study [27] in
this review. The classes of AM used included penicillin
(amoxicillin) and potentiated sulphonamides (sulfameth-
oxazole, sulfadiazine, and trimethoprim). There was no
recorded use of AM classed as Category A, B or C in
those crops.
The research analysed the number of diagnoses that
received a prescription for an AM and categorised the
results by diagnosis group. Nearly all diagnoses of young
chick diseases received a prescription and nearly half of
the diagnoses for intestinal disease received a prescrip-
tion; almost half of all AMU occurred in the first week
of life [27].
Dairy cattle
No data were available to estimate the overall quan-
tities of AM used in the dairy industry. AMU in dairy
calves representing calves reared in dairy-calf-to-beef
systems has been studied and is discussed under beef
cattle [25]. At a national level, only intramammary
AMU has been described. More and colleagues used
national sales and prescription data to describe trends
in both intramammary Dry Cow Therapy (DCT) and
intramammary Lactation Therapy (LT) AMU in dairy
herds in Ireland [22, 23].
Sales of DCT intramammary products increased from
2003 to 2015 by approximately 106,000 tubes per year
from a baseline of 2,250,000 [23]. The number of teat
sealants sold also increased, indicating that farmers were
using teal sealants in conjunction with, rather than as an
alternative to using intramammary AM products. How-
ever, work by McAloon and colleagues (in review) has
demonstrated a decline in DCT AMU between 2015 and
2019. In addition, the dairy industry has made a
Fig. 3 Distribution of sales (based on tonnes sold) of veterinary antimicrobials supplied from 2014 to 2018 in Ireland, by AM class [28–32]
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concerted move towards Selective Dry Cow Therapy
(SDCT) under the umbrella of the CellCheck mastitis
control program of Animal Health Ireland [37]. In con-
trast, there was a decrease in sales of LT intramammary
products of approximately 26,000 tubes per year from
2003 to 2015 [23].
The classes used in intramammary AM products
for DCT included aminoglycosides, cephalosporins
and penicillins [23]. The use of 1st generation ceph-
alosporins, categorised by the EMA as Category C in
DCT products has increased steadily to a figure of
481 kg (quantity of active substance) in 2015 from a
baseline of 147 kg in 2003 [23]. In LT tubes, the
classes of AM used included aminocoumarin, amino-
glycosides, cephalosporins, lincosamides, penicillins
and sulphonamides. Macrolides and tetracyclines
have not been present in LT intramammary products
since 2005 and 2009, respectively. However, there
has been continuous use of Category C 1st gener-
ation cephalosporins, and Category B 3rd and 4th
generation cephalosporins in LT intramammary
products over the period studied. Whilst there was
an overall decrease in the quantity of active sub-
stance in LT intramammary tubes sold over the
years, there was an increase in the sale of products
containing 4th generation cephalosporins, with over
3 times as many 4th generation cephalosporins sold
in 2015 than in 2003 [23].
Beef cattle
No data were available to estimate the overall quan-
tities of AM used in the beef industry. The only re-
search published to date in this area has quantified
use in 0–6-month-old beef and dairy calves and the
contribution of adult beef cattle has not yet been
studied [25, 38]. Earley and colleagues studied AMU
in the two main calf-rearing systems in Ireland, suck-
ler calf-to-beef and dairy calf-to-beef. The average
AMU for suckler beef calves from birth to six months
was 7.25 mg/PCU with approximately two-thirds of
that given in the first month of life and with 20.4% of
suckler beef calves treated with AM for at least one
disease event [25]. Dairy calves had an average AMU
of 7.11 mg/PCU and 14.8% of dairy-bred calves were
treated with AM at least once.
The AM prescribed most for dairy and suckler-beef
calves during the study period were penicillin, mainly
amoxicillin, tetracyclines mainly oxytetracycline,
amphenicols (florfenicol) and fluoroquinolones (enro-
floxacin and marbofloxacin) [25]. Fluoroquinolones,
which are classed as Category B antimicrobials by the
EMA, ranked highest in terms of Treatment Incidence
(TI) across all calves in this study.
Sheep
No data were available to estimate the quantities of AM
used in the sheep industry, either at an overall level or
within a particular age group or specific use.
Discussion
This study highlights a significant deficit in the know-
ledge of AMU at sector-level in farmed animals in the
Republic of Ireland. Currently, the only national-level
AMU data is derived from sales data of veterinary AM
medicines, and there are issues with sales data that need
to be considered. Firstly, the figures are not corrected
for population size, therefore fluctuations in sales may
reflect changes in the national herd size. Furthermore,
sales do not necessarily equate to on-farm use of AM
and these figures do not consider AM which are held in
stock. Additionally, the sales data includes sales of veter-
inary AM for use in companion animals, which may ac-
count for a larger proportion than expected. However,
accepting these issues, some useful interpretations may
be taken from the data. For example, while most
pharmaceutical forms are used across sectors and there-
fore cannot be attributed to a specific industry, it is pos-
sible to relate the sales of intramammary products to the
dairy sector. Furthermore, combining sales data with
findings from research studies can help identify major
gaps and possible attribution of sales data. For example,
it was previously suspected that the cattle industries
contribute little to the overall quantity of AM used when
compared to more intensive industries such as pigs and
poultry. However, further to recent research in the pig
and poultry industries, up to 19 t of oral veterinary AM
sold nationally are not accounted for in these industries
[27, 36, 39]. It is possible that a large proportion of the
approximate 19 t of oral AM sold may be attributed to
use in the cattle industries for the treatment of sick
calves. While the use of oral AM in calves in Ireland has
been mentioned in literature [40], as yet no studies have
investigated the quantities used for this purpose. Fur-
thermore, the contribution of oral AMU in laying hens
has not been considered. Sector-level data collection is
needed to accurately attribute sales of oral AM to use in
a specific industry.
The collection of sector-level data will add value to the
sales data gathered, currently in Ireland, veterinary AM
consumption is categorised by antimicrobial classes and
pharmaceutical form sold [28]. In contrast, in countries
such as Denmark and the Netherlands, sector-level data
collection has allowed the distribution of AM consump-
tion to be categorised by the main species [10, 13]. Cate-
gorising use by species has allowed these countries to
identify the main industries driving AMU in the country
and therefore implement targeted reduction strategies.
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While AMU data is not routinely collected for all spe-
cies at sector-level in Ireland surveillance studies have
provided insights into the quantities of AM used at
sector-level, however, the quality of data available varies.
Across the sectors, the pig industry has collected the
most robust data on overall use, including quantities
used, classes used and routes of administration. The
quality of the data collected has allowed for estimates of
overall use to be calculated and a large proportion of na-
tional sales to be accounted for. In 2016, the pig sector
was estimated to have used 43.5 t of the veterinary AM
sold [36], being 42% of total veterinary AM sold that
year (103.4 t) [31].
Unlike the pig industry, less intensive industries
have not gathered sufficient data to calculate a figure
of overall use within the sector. Within the dairy in-
dustry, the data collected on intramammary AMU by
More and colleagues has provided invaluable informa-
tion on the use of intramammary products [22, 23].
However, a major limitation of this research is that
only intramammary AM are discussed, the contribu-
tion of injectables or intrauterine AM are not consid-
ered. In a study conducted in the UK by Hyde and
colleagues evaluating AMU on British dairy farms,
intramammary products only made up 12.5% of AM
used or sold, whereas injectables made up 78.1% [41].
The lack of data available, both at sales or prescriber
level or indeed at farm level on non-intramammary
AMU in the dairy sector is a challenge that will have
to be overcome in order to better quantify AMU
within this industry.
In addition to the forms of AM measured, the popula-
tion studied can influence the quality of the AMU data
collected. In research in the pig and poultry industries,
the sample population included all age groups on the
study farms [27, 36], thus allowing for a figure of overall
use within the sector to be calculated. In other sectors,
the contribution of each age group to overall use has not
been considered. Studies which evaluate usage across all
age groups on the farm glean a more holistic view of
AMU across the sector, the exclusion of certain groups
may affect the comparability of the data.
The comparability of animal production AMU data is
a current issue in Ireland. Although some AMU data has
been collected in most livestock species, it is difficult to
make cross species comparisons due to the difference in
metrics used to quantify use. The research studies in-
cluded in this review used varying methods for quantify-
ing AMU such as mg/PCU, DDDvet and DCDvet, or
Treatment Incidence (TI). There are benefits to each in-
dicator used, however, the results cannot be aggregated
to compare trends across different sectors if there is in-
consistency in the metrics used to quantify use. The in-
dicators could be harmonised if there was open access
to the raw data or a unified database, however neither
are currently available in Ireland.
To allow for robust comparisons across countries, rec-
ommendations for the most suitable metrics to use when
quantifying country-level AMU to incorporate usage
across all species should be considered. Collineau and
colleagues published a review on the selection of appro-
priate indicators for the quantification of AMU in
humans and animals [42]. This review highlights the
challenge of making comparisons between populations;
the differences in AM products, treatment protocols and
the population at risk hamper the comparability of any
data collected [42]. Collineau and colleagues recommend
the preferred use of dose and course metrics for
country-level comparisons, with sector-level mg/PCU as
an acceptable alternative. Mills and colleagues suggested
that country-specific versions of the daily dose and
course metrics would improve representativeness but
note that tailoring the metrics may prove impractical in
the short-term and the current standardised ESVAC
dose and course metrics (DDDvet and DCDvet) are a vi-
able alternative [43]. Currently overall mg/PCU is the
metric used by the EMA in their annual reports on vet-
erinary AMU, and it is also used by the European Food
Safety Authority (EFSA) and European Centre for Dis-
ease Control (ECDC) to monitor AMU and AMR in
food-producing animals [44]. However, care should be
taken when using mg/PCU for country-level compari-
sons, as it is heavily influenced by the relative size of dif-
ferent sectors in terms of biomass and use within each
sector [45]. Sector-level values of mg/PCU would allow
for cross-species comparisons and more accurate com-
parisons at country-level.
The latest ESVAC report published by the EMA in
2019, describes trends in AM sales for all food-
producing species, expressed in mg/PCU, for 25 EU
member states from 2011 to 2017 [33]. As mentioned,
country-level comparisons using overall mg/PCU should
be interpreted with caution, given the size differences of
farming sectors in terms of biomass and differences in
use within each sector. Ireland has shown comparatively
low levels of overall usage, 46.6 mg/PCU, however re-
search in the pig sector has shown AMU levels of 161.9
mg/PCU [35], which is not reflected in the overall mg/
PCU as the pig sector accounts for a small percentage of
total biomass [46]. Ireland’s predominant livestock sec-
tor is cattle, where AMU is typically low, therefore
country-level mg/PCU will be favourable. Overall usage
has appeared consistent in Ireland during this period
(2011–17), however, within-country temporal trends in
overall mg/PCU will be influenced by fluctuations in the
national herd size. The increase in the size of the cattle
herd (in terms of biomass) accompanied by a flatline
trend in overall use may actually represent an increase
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in mg/PCU in the non-cattle sectors. Accepting the is-
sues with mg/PCU as a metric for country-level compar-
isons, some useful interpretations can be taken from the
ESVAC report. The report shows that overall sales of
veterinary AM fell by more than 32% between 2011 and
2017, with some of the largest reductions in countries
with the highest usage initially [33]. However, usage has
appeared consistent in Ireland whilst declining in other
countries. For example, the UK, have decreased their
AMU, in terms of mg/PCU, by almost 50% in the last 5
years, with reductions in each sector’s mg/PCU [14].
The sales figures suggest Ireland has fallen behind in ef-
forts to reduce global veterinary AMU and progress
made in member states highlights the need for change in
Ireland. The overall decline in sales has been achieved
through the introduction of targeted AMU reduction
strategies, including among others, increased monitoring
of use, benchmarking, restrictions on use and the intro-
duction of national reduction targets [33]. Ireland’s Na-
tional Action Plan on AMR (iNAP) will be revised in
2020, which provides an opportunity to learn from the
success of other EU member states and incorporate im-
proved reduction strategies into the next stages of the
plan.
The ability for Ireland to reduce national veterinary
AMU will be greatly increased if the monitoring of
AMU can be improved. The sector-level data collected
in surveillance studies has provided valuable information
on AMU in farmed animals albeit on a small scale. To
monitor AMU at a larger scale in the pig industry,
DAFM have introduced an AM data collection system,
‘AMU Pig’, for commercial pig herds in Ireland, which
will report usage in mg/PCU [47]. Approximately 300–
400 commercial pig herds (herds slaughtering > 200 pigs
per annum) were invited to register for the system, in
which farmers will input their AMU quarterly. Currently
the system is voluntary, but it will become a requirement
for participation in the Bord Bia Pig Quality Assurance
Scheme (PQAS) in 2020 and a requirement by EU law
in January 2022. Within the poultry industry, DAFM is
currently working to produce a national AMU figure for
the broiler sector [39]. The layer sector will also need to
be considered to provide a comprehensive picture of
AMU in the Irish poultry industry. Additionally, the im-
plementation of new EU legislation will result in the col-
lection of AMU data in the less intensive livestock
industries, such as dairy, beef and sheep. Figure 4 pro-
vides a timeline of events in AMU data collection in the
animal health sector in Ireland.
The development of AMU surveillance systems will
allow for national use to be monitored and reported.
In addition to monitoring trends in AMU at both
sector and national level, the availability of usage data
will allow Ireland to benchmark farms and veterinar-
ians. Benchmarking has proven to be useful in redu-
cing AMU in other EU member states, such as the
Netherlands [13] and Denmark [10]. However, while
the collection of AMU data will be valuable for moni-
toring progress, it comes with its own set of chal-
lenges. DAFM anticipate that AMU data from all
food-producing animals except pigs will initially be
gathered from the veterinarians prescribing the medi-
cines [48]. While prescription data provides a more
comprehensive picture of AMU than sales data, there
is a possibility of over-reporting as the quantities used
by the farmer, the end-user of the product, may be
Fig. 4 Timeline of events in the collection of AMU data in Ireland
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different from that prescribed. The quantification of
AMU from prescription data may also be challenging
in sectors with traditionally low veterinary involve-
ment, such as sheep. The obtainment of accurate
farm-level usage records would be ideal, however the
feasibility of obtaining robust and accurate usage re-
cords from all farms in Ireland is uncertain. Farmers
are required to record usage data. However, maintain-
ing accurate records requires commitment from all
those working with livestock, and without any incen-
tives, farmers may lack the motivation to report use
resulting in underreporting.
This review provides an insight into current AMU in
animal production in the Republic of Ireland and high-
lights the need for robust AMU data collection across all
livestock sectors. The standardisation of data collection
methods will allow for comparison within and between
species. AMU data collection systems will be developed
in the future to ensure Ireland complies with EU regula-
tions however there will be challenges in collecting ro-
bust and accurate data. In the short term, smaller
surveillance studies would be beneficial to build on
knowledge of AMU in food-producing animals, espe-
cially in less intensive industries such as beef and sheep,
where information is currently lacking.
Conclusion
The development of AMR is a continuing threat for
humans and animals; thus it will be important to moni-
tor AMU and AMR at practice and farm-level across all
production sectors. This review has highlighted signifi-
cant gaps in the knowledge of AMU in food-producing
animals in the Republic of Ireland. Farm-level usage data
will provide insight into the trends of use and allow for
targeted interventions. The efficacy of reduction strat-
egies will be improved if they can be targeted at specific
behaviours, patterns of use and specific high usage
farms. While progress has been made in the pig and
poultry sectors, the less intensive industries such as the
beef and sheep sectors, have a long way to go with
regards to providing a comprehensive overview of AMU,
progress cannot be demonstrated in the absence of data
collection.
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